Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check2 days agoChange DetectedA new version entry for v3.6.3 was added to the study record history and the older v3.6.2 entry was removed, indicating an updated revision of the record.SummaryDifference0.1%

- Check9 days agoChange DetectedThe Record History now shows a new Revision: v3.6.2 entry, replacing the earlier Revision: v3.6.0. This reflects an update to the study record version within the history view.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe study history now shows that the trial is no longer recruiting participants, and the record version has been updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.4%

- Check30 days agoChange Detected- An updated revision entry was added to the record history: Revision: v3.5.5. The previous entry Revision: v3.5.4 was removed, indicating a minor version-history update to the page.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry labeled v3.5.4 appears in the Record History, replacing the previous v3.5.3. This indicates a minor update to the page’s revision log rather than changes to the study data.SummaryDifference0.1%

- Check59 days agoChange DetectedIndiana University School of Medicine was replaced by Indiana University as the 'Information provided by' affiliation for the study record. This updates the institutional attribution and the responsible party associated with the study's information.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.